drugset / Trial / NCT00147771

Imiquimod in Children With Plaque Morphea

NCT00147771

Phase 3 Completed 10 enrolled The Hospital for Sick Children
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Morphea is very hard to treat. In a small number of adult patients, Imiquimod has proven to be beneficial in decreasing the thickness of the morphea plaques , while improving their appearance. There are no studies to date proving its safety and efficacy in children with this disease. We propose to conduct a pilot study to assess to potential efficacy and relative safety of Imiquimod in children with plaque morphea.

Timeline

Start
2005-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 % Topical

Indications